Abstract
Mark Caulfield is chief scientist at Genomics England, which was set up in 2013 to deliver the UK 100,000 Genomes Project, initially focusing on cancers, rare diseases and infection. Caulfield, a cardiovascular clinician and researcher, spoke about the UK approach to big data in biomedicine and the role of Genomics England — including how it plans to embed genomic medicine in Britain's National Health Service (NHS).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
